Core Viewpoint - The announcement from Xiangyuan Culture and Tourism clarifies that the overdue financial products are related to its controlling shareholder, Xiangyuan Holdings, and that the company itself is not liable for any repayment obligations [1][4]. Group 1: Company Response - Xiangyuan Culture and Tourism confirmed that there are overdue payments on financial products issued on a platform related to real estate projects with Xiangyuan Holdings, which bears joint guarantee responsibility [1][5]. - The company stated that the overdue financial products are unrelated to Xiangyuan Culture and Tourism and its subsidiaries, and the company does not bear any repayment or guarantee obligations [1][5]. - The company's operations are currently normal, and management has committed to maintaining independence from its controlling shareholder in various aspects [1][5]. Group 2: Industry Context - Other companies, such as Jiaojian Co. and Haichang Ocean Park, have also issued announcements regarding the situation [2]. - The Zhejiang Financial Assets Trading Center's financial asset trading qualifications were revoked as of October 2024, indicating a significant regulatory change in the industry [3]. - The Zhejiang Provincial Financial Management Bureau announced that there will no longer be financial asset trading venues in the province, although existing legal responsibilities will still be upheld [3].

12月8日，A股三大指数小幅高开，截至9：50左右，A股主要股指集体飘红。 | 上证指数 | 深证成指 | 北证50 | | --- | --- | --- | | 3906.27 | 13193.42 | 1418.69 | | +3.46 +0.09% +45.74 +0.35% +10.35 +0.73% | | | | 科创50 | 创业板指 | 万得全A | | 1332.26 | 3137.34 | 6275.00 | | +6.15 +0.46% +28.04 +0.90% +24.36 +0.39% | | | | 沪深300 | 中证500 | 中证A500 | | 4595.33 | 7118.50 | 5525.37 | | +10.79 +0.24% +20.66 +0.29% +11.61 +0.21% | | | （文章来源：21世纪经济报道） | 资料 | 成分 | 资讯 | 相关基金 | 月度收益 | | --- | --- | --- | --- | --- | | 兴业证券 | | 7.92 | 10.00% | 0.00% | | 601377.SH | | | | | ...

记者丨黎雨桐 编辑丨金珊 12月8日，A股三大指数小幅高开，截至9：50左右，A股主要股指集体飘红。 | 上证指数 | 深证成指 | 北证50 | | --- | --- | --- | | 3906.27 | 13193.42 | 1418.69 | | +3.46 +0.09% +45.74 +0.35% +10.35 +0.73% | | | | 科创50 | 创业板指 | 万得全A | | 1332.26 | 3137.34 | 6275.00 | | +6.15 +0.46% +28.04 +0.90% +24.36 +0.39% | | | | 沪深300 | 中证500 | 中证A500 | | 4595.33 | 7118.50 | 5525.37 | | +10.79 +0.24% +20.66 +0.29% +11.61 +0.21% | | | A股券商股再度拉升，兴业证券直线涨停，东北证券涨超7%，中银证券、华泰证券、国泰海通、中信证券、广发证券等跟涨。 | 2 | | --- | CPO板块持续拉升，中际旭创股价一度创历史新高，报559.88元。天孚通信涨超11%，通宇通讯、中瓷电子 ...

| 代码 | 名称 | 两日图 | 现价 | 涨跌 | 涨跌幅 | | --- | --- | --- | --- | --- | --- | | 000001 | 上证指数 | 1- 2 | 3909.23 | 6.42 | 0.16% | | 399001 | 深证成指 | | 13178.96 | 31.28 | 0.24% | | 399006 | 创业板指 | W | 3119.15 | 9.85 | 0.32% | 个股方面，安妮股份一字涨停。公司公告，控股股东拟约7.72亿元转让15.92%股份，交易完成后公司实控人将变更为李宁、王磊。 | R | | 安妮股份 002235 | 0.42% 1040 | | 同行对比 | | --- | --- | --- | --- | --- | --- | | | | 10. 22 +0.93 +10.01% | 资金分析(万元) | | ? 排名 | | 委比 +100.00% 2112743 | न्द्रे | | 王力流入: 卖 | | | | | | | 1021.6 | 18% | | | 5 | | | | | 32% | | F | | ...

2025.12. 08 本文字数：639，阅读时长大约1分钟 作者 | 一财 阿驴 09:29 大金融板块继续走强，瑞达期货2连板，兴业证券、国信证券、华泰证券、湘财股份、国泰海通 等纷纷高开。 09:25 A股开盘丨三大指数集体高开 沪指高开0.16%，深成指高开0.24%，创业板指高开0.32%。盘面上，玻璃纤维股走强，商业航天，炒 股软件、券商、大飞机指数涨幅居前。 | 代码 | 名称 | 两日图 | 现价 | 涨跌 | 涨跌幅 | | --- | --- | --- | --- | --- | --- | | 000001 | 上证指数 | 1- 2 | 3909.23 | 6.42 | 0.16% | | 399001 | 深证成指 | | 13178.96 | 31.28 | 0.24% | | 399006 | 创业板指 | | 3119.15 | 9.85 | 0.32% | 个股方面，安妮股份一字涨停。公司公告，控股股东拟约7.72亿元转让15.92%股份，交易完成后公司 实控人将变更为李宁、王磊。 | R | 安妮股份 002235 | 造纸 10 | | 0.42% | | 同行对比 | ...

Core Viewpoint - Xiangyuan Holding Group's financial asset income rights products have defaulted on payments, leading to rumors of "default" and "explosion" [1] Group 1: Company Response - Xiangyuan's listed companies, Xiangyuan Cultural Tourism and Jiaojian Co., issued announcements clarifying that the financial products in question are unrelated to them and that they do not bear any guarantee responsibilities [1] - Both companies confirmed that they are not responsible for any payment obligations related to the defaulted products and have not provided guarantees for any financial products [1][2] Group 2: Financial Product Details - The defaulted products had an average yield of approximately 4%-5% and were issued based on Xiangyuan Holding Group's original real estate projects [2] - At least ten companies under Xiangyuan are listed on the overdue list, with a total overdue balance exceeding 37 million yuan [2] Group 3: Platform Information - Zhejiang Financial Center, established in December 2013, is involved in bad asset transfer and investment income rights [2] - The center's financial asset trading qualifications were revoked as of October 31, 2024, and no new products are being released on its app, although existing products can still be transferred and purchased [2] Group 4: Lack of Disclosure - Xiangyuan Holding Group has not disclosed the total amount of the defaulted products or provided any formal statements regarding the distribution of payment responsibilities, compensation arrangements, or settlement plans [3]

Group 1: National Medical Insurance Directory Inclusion - Heng Rui Medicine has multiple drugs included in the 2025 National Medical Insurance Directory [1] - Xing Qi Eye Medicine has 39 products continuing to be included in the National Medical Insurance Drug Directory [1] - Bei Da Pharmaceutical has four products included in the National Medical Insurance Drug Directory [1] - Junshi Biosciences has added indications for Tuoyi® and included Junshida® in the National Medical Insurance Directory [1] - Zhongsheng Pharmaceutical's innovative drug Angladiwei tablets have been included in the National Medical Insurance Directory through negotiation [1] - Yiling Pharmaceutical's subsidiary has its exclusive product Qifang Nasal Tablets included in the National Medical Insurance Directory, totaling 12 exclusive patented traditional Chinese medicine products [1] - Aosaikang's product Liratinib tablets (Aoyi Xin®) has been included in the 2025 National Medical Insurance Directory [1] - Kanghong Pharmaceutical's product Kangbai Xip eye injection (Langmu) has been included in the 2025 National Medical Insurance Directory [1] - Dongcheng Pharmaceutical's Technetium-99m injection has been included in the medical insurance directory; its subsidiary has received clinical trial approval for 177Lu-LNC1009 injection [1] - Micron Biomedical's Sidabena tablets have been included in the National Medical Insurance Directory for regular Class B management [1] - Haichuang Pharmaceutical's Deuteroenzalutamide soft capsules have been included in the National Medical Insurance Directory for the first time [1] - Huadong Medicine's subsidiary products and cooperative products have been included in the National Medical Insurance and commercial insurance innovative drug directory [1] - Aidi Pharmaceutical's two anti-HIV innovative drugs continue to be included in the National Medical Insurance Directory through a simplified renewal process [1] Group 2: Corporate Developments - Hengyin Technology has signed a cooperation agreement with Muxi Co., focusing on the domestic GPU scenario [1] - Jia Jian Co. is planning a change in control, with stock resuming trading on December 8 [2] - Gu Ao Technology's actual controller is planning a change in control, leading to stock suspension [2] Group 3: Financial Performance - Tianbang Food reported a commodity pig sales revenue of 654 million yuan in November, a month-on-month increase of 7.66% [3] - Tian Ci Materials' controlling shareholder has committed not to reduce company shares [3]

Group 1 - The China Securities Regulatory Commission (CSRC) Chairman emphasized the need to moderately expand the capital space and leverage limits for brokerages, shifting from price competition to value competition, and promoting internationalization of brokerages to enhance cross-border financial services [1] - The China Insurance Regulatory Commission announced a reduction in risk factors for certain stock holdings by insurance companies, potentially bringing over 100 billion yuan of incremental funds to the stock market [1] - The National Medical Insurance Administration added 114 new drugs to the national medical insurance catalog, including 50 innovative drugs, which could significantly impact the pharmaceutical sector [1] Group 2 - A super factory in Wenchang International Aerospace City is set to produce 1,000 satellites annually, marking a significant advancement in China's satellite manufacturing capabilities [2] - The World Gold Council reported that ETF holdings increased to 3,932 tons by the end of November, with China being the largest contributor to this growth [2] - The stock market saw significant activity with the debut of domestic GPU company Moore Threads on the STAR Market, achieving a closing price of 600.5 yuan per share, marking a 425.46% increase [3] Group 3 - The Shanghai Stock Exchange reported a total dividend payout of 1.81 trillion yuan from listed companies in the first eleven months, indicating a 2% year-on-year increase [5] - Companies like Midea Group are advancing in robotics, focusing on various categories of humanoid robots, while China Telecom launched a cross-border optical fiber transmission system [6] - The semiconductor industry is experiencing a surge, with global sales increasing by 33% year-on-year, driven by demand for AI infrastructure [15] Group 4 - The Ministry of Commerce is promoting durable goods consumption and reforming the automotive circulation sector to stimulate economic growth [10] - The National Medical Insurance Administration and the Ministry of Human Resources and Social Security are pushing for the inclusion of innovative drugs in commercial health insurance, which could enhance the pharmaceutical market [13] - The price of tin has reached a three-year high due to supply disruptions and rising demand from emerging sectors like AI and automotive electronics [14]

2025.12.08 本文字数：930，阅读时长大约1.5分钟 12月7日，祥源文旅（600576）公告称，公司实际控制人承担连带保证责任的金融产品出现部分逾期兑 付的媒体报道并引发投资者关注。公司就相关事项向祥源控股及公司实际控制人进行了核实并进行自 查。为避免不实信息误导市场，保障投资者合法权益，现作如下说明： 1、在某平台发行的涉及与祥源控股地产合作项目的金融产品存在部分逾期兑付情形，祥源控股、公司 实际控制人就上述兑付义务承担连带保证责任。祥源控股及公司实际控制人正与相关方就逾期兑付的具 体情况进行沟通处理。 2、本次事件涉及的金融产品与祥源文旅及其参、控股子公司均无关，祥源文旅不承担任何兑付及担保 义务，公司亦未为任何金融理财产品的兑付提供担保或增信。 3、公司目前生产经营一切正常。公司管理层承诺遵照《上市公司治理准则》，确保与控股股东、实际 控制人在资产、人员、财务、机构及业务等方面的独立。 此外，交建股份（603815）、海昌海洋公园（02255.HK）也发布公告进行说明。 12月6日，据媒体报道，祥源控股集团有限责任公司（以下简称"祥源控股"）在浙江金融资产交易中心 股份有限公司（以下简称"浙 ...

2025.12. 08 本文字数：930，阅读时长大约1.5分钟 12月7日， 祥源文旅 （600576） 公告称， 公司实际控制人承担连带保证责任的金融产品出现部 分逾期兑付的媒体报道并引发投资者关注。 公司就相关事项向祥源控股及公司实际控制人进行了核 实并进行自查。为避免不实信息误导市场，保障投资者合法权益，现作如下说明： 1、在某平台发行的涉及与祥源控股地产合作项目的金融产品存在部分逾期兑付情形，祥源控股、公 司实际控制人就上述兑付义务承担连带保证责任。祥源控股及公司实际控制人正与相关方就逾期兑付 的具体情况进行沟通处理。 2、本次事件涉及的金融产品与祥源文旅及其参、控股子公司均无关，祥源文旅不承担任何兑付及担 保义务，公司亦未为任何金融理财产品的兑付提供担保或增信。 3、公司目前生产经营一切正常。公司管理层承诺遵照《上市公司治理准则》，确保与控股股东、实 际控制人在资产、人员、财务、机构及业务等方面的独立。 值得一提的是，2024年10月， 浙金中心的 金融资产交易业务资质已被取消。 浙江省地方金融管理局发布公告称，不再保留浙江金融资产交易中心股份有限公司（浙金中心）金融 资产交易业务资质。"自本公告 ...